Results 71 to 80 of about 3,832,801 (301)

Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli   +5 more
wiley   +1 more source

How China Governs Open Science: Policies, Priorities, and Structural Imbalances

open access: yesPublications
This article investigates the architecture and institutional distribution of policy tools supporting open science (OS) in China. Based on a corpus of 199 policy documents comprising 25,885 policy statements, we apply an AI-assisted classification to ...
Xiaoting Chen   +2 more
doaj   +1 more source

The pricing of academic journals: A two-sided market perspective [PDF]

open access: yes
More and more academic journals adopt an open-access policy, by which articles are accessible free of charge, while publication costs are recovered through author fees. We study the consequences of this open access policy on a journal’s quality standard.
Doh-Shin Jeon, Jean-Charles Rochet
core  

“Open” or “half-open” Access?: Re-thinking Open Access Initiative (OAI) Policies.

open access: yesObservatorio (OBS*), 2013
The goal of this paper is to review critically the concept of "open access" of the Open Access Initiative (OAI), and consequently their policies. Considering the technological and behavioral changes underway in society, we advocate a broader scope of the meaning of “open access”.
openaire   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

One university different modes of delivery: An analysis of lecturers’ teaching experiences in conducting ICT practical sessions at a rural Eastern Cape university during the COVID-19 pandemic

open access: yesJournal of Studies in Social Sciences and Humanities
In this empirical paper, we analysed lecturers’ teaching experiences in practical sessions in ICT during the COVID-19 pandemic at a rural university. The reason for writing this paper is to provide new insights into existing literature in that although ...
Anthony Kambi Masha*   +2 more
doaj  

Offen, verantwortlich und verantwortlich offen

open access: yesTATuP – Zeitschrift für Technikfolgenabschätzung in Theorie und Praxis, 2017
Sowohl Open Science als auch Responsible Research and Innovation (RRI) zielen auf tiefgreifende Transformationen im Innovationssystem durch eine stärkere Öffnung von Forschung und Entwicklung für gesellschaftliche Akteure.
Johann Jakob Häußermann   +1 more
doaj   +1 more source

Introduction [PDF]

open access: yes, 2015
The short editorial introduces to the new issue of the Review. Startgin from the 2015 volume, the journal has changed its copyright policy as well as its open access ...
D'Ippoliti, Carlo
core  

JRC Data Policy [PDF]

open access: yes, 2015
The work on the JRC Data Policy followed the task identified in the JRC Management Plan 2014 to develop a dedicated data policy to complement the JRC Policy on Open Access to Scientific Publications and Supporting Guidance, and to promote open access to ...
ANNONI Alessandro   +11 more
core   +1 more source

Public (open) access policy [PDF]

open access: yesEpilepsia, 2008
Philip A, Schwartzkroin   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy